Clinical Trial Update: Prospekta in the Treatment of Cognitive, Behavioral and Psychiatric Disorders in Patients With Vascular Dementia. [Phase 3]

View source ↗

Summary

Phase 3 trial update for Prospekta evaluating cognitive, behavioral, and psychiatric symptoms in vascular dementia; results have been posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vascular Dementia

Drugs mentioned

• Prospekta

Snippet

Sponsor: Materia Medica Holding | Conditions: Vascular Dementia | Phase 3 | Status: COMPLETED | Results posted: 2024-10-28